Regulatory T-cell immunity and its relevance to atherosclerosis.
about
High-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting MechanismsThe ubiquitin-proteasome system and cardiovascular diseaseHDAC4 mediates development of hypertension via vascular inflammation in spontaneous hypertensive rats.On to the road to degradation: atherosclerosis and the proteasomeThe effect of cyclic mechanical strain on activation of dendritic cells cultured on adhesive substrates.T regulatory lymphocytes and endothelial function in pediatric obstructive sleep apneaBone marrow deficiency of MCPIP1 results in severe multi-organ inflammation but diminishes atherogenesis in hyperlipidemic mice.Lymphocytes in atherosclerosis.Heat shock protein 60 and immune inflammatory responses in atherosclerosisActivation of T lymphocytes in atherosclerotic plaques.Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans.Immune effector mechanisms implicated in atherosclerosis: from mice to humans.Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.Association of single-nucleotide polymorphisms in JAK3, STAT4, and STAT6 with new cardiovascular events in incident dialysis patientsTranslational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.Pigment epithelium-derived factor alleviates endothelial injury by inhibiting Wnt/β-catenin pathway.Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome.Obesity and susceptibility to autoimmune diseases.Targeting inflammation in cardiovascular diseases. still a neglected field?Telomere length in cardiovascular disease: new challenges in measuring this marker of cardiovascular aging.Regulatory T cells, mTOR kinase, and metabolic activity.At the crossroad of T cells, adipose tissue, and diabetes.Immune mechanisms in hypertension.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis.Immune-mediated mechanisms of atherosclerosis and implications for the clinic.Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans.Activation of human vascular cells decreases their expression of transforming growth factor-beta.Workflow for generating competing hypothesis from models with parameter uncertainty.Impact of chronic methamphetamine treatment on the atherosclerosis formation in ApoE-/- mice fed a high cholesterol diet.Changes in CD4+CD25+ Tregs in the pathogenesis of atherosclerosis in ApoE-/- mice.HIV and Cardiovascular Disease: Role of Immunometabolic Perturbations.Relationship Between Hematologic Indices and Global Registry of Acute Coronary Events Risk Score in Patients With ST-Segment Elevation Myocardial Infarction.Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells.The Pivotal Role of Thymus in Atherosclerosis Mediated by Immune and Inflammatory Response
P2860
Q26774658-968E10C5-C464-4F64-9F16-1D83F22950C8Q27021582-1E5A2875-6CE4-407B-8A6A-DA743999C2EAQ29347006-1BCB9872-1A99-41A5-BB95-8D82B6D452C7Q33554513-474D123B-9B4C-479D-953F-DA656AEB983BQ33998354-C0A4A822-794D-4ECB-A53C-5417CBA6FA96Q34920980-BFFB7926-546D-4023-84A1-6C8F3912E534Q35040388-9F40065D-C0DD-40C7-9BB7-7CB2A6475FE4Q35082438-503E376B-0787-42EE-BF30-7032FC3C7754Q35540113-FD96E7E2-7C6B-4024-BA9A-B4F390178844Q36106042-7D14AA56-4C4E-4908-8E2A-7746B556DE34Q36139395-6EC498B3-1159-4196-AC69-34BAABC20917Q37150605-D85CB31E-8773-4A50-8B2B-A93A1E7753C4Q37230396-2EB811AD-E8CE-4A82-93A6-72414F19C025Q37347718-44B7348D-4D8B-4FB3-9597-951091B13281Q37421814-AF178F91-4D79-455A-876C-2880B6E0179AQ37631043-1554027E-09B8-4528-AAFC-B70F41FEB56EQ37680386-29A3EF93-1EF0-43BE-9126-694AB25A22DEQ37877257-BD25D17E-A541-49F3-B387-58B64058069FQ37925018-209B27F5-269F-4A80-B43A-36FA7242B83BQ37952252-135948F9-6716-4D28-B145-0489C614105AQ38023734-59406B6A-6DD7-4870-A619-671F5B11281EQ38034269-1C33355D-D0FE-4489-AA70-9EBA8284186BQ38180419-62601080-F764-400A-AFEE-04AF5DD1D2B7Q38620803-EBA6071B-B9E3-45BE-B401-7BD922E141A7Q38788255-1A1BBBD9-03AC-4D4F-A0A9-F8626C15FB37Q38851472-E04CD2AC-77B2-4016-9B45-DEE44036DFD3Q38918734-7BCC8BF4-8291-44D2-958C-4F47C3ACA8C3Q39469873-8387E7EC-7929-4F5D-A725-76F60F59F705Q40543545-D0197599-3FCE-447A-8FC3-5148815BB0D5Q41549706-F243B864-90E3-4F39-B84B-EDB18358345FQ43104927-1C998297-94A3-4BFB-8241-A02E1171E6B1Q50045865-7F9B0F6C-9C63-43C1-B58B-D10773B217CBQ50471718-585EE0C5-3941-4B50-AA0C-E96C380BD336Q51758326-D1771690-501F-4E3B-B319-11396C2C9E1BQ59133277-26FFC260-3D95-4F2B-9F3A-7BD24CCEA67C
P2860
Regulatory T-cell immunity and its relevance to atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regulatory T-cell immunity and its relevance to atherosclerosis.
@en
Regulatory T-cell immunity and its relevance to atherosclerosis.
@nl
type
label
Regulatory T-cell immunity and its relevance to atherosclerosis.
@en
Regulatory T-cell immunity and its relevance to atherosclerosis.
@nl
prefLabel
Regulatory T-cell immunity and its relevance to atherosclerosis.
@en
Regulatory T-cell immunity and its relevance to atherosclerosis.
@nl
P2860
P1476
Regulatory T-cell immunity and its relevance to atherosclerosis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2796.2008.01944.X
P407
P577
2008-05-01T00:00:00Z